A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients
De Pas, Tommaso, Putzu, Carlo, Curigliano, Giuseppe, Noberasco, Cristina, Sabrina, Boselli, Catania, Chiara, Orlando, Laura, Milani, Alessandra, Spaggiari, Lorenzo, de Braud, FilippoVolume:
54
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2006.08.016
Date:
December, 2006
File:
PDF, 210 KB
english, 2006